Evidence map›Paper›PMID 39795819›Full record

ArticleMaterials (Basel, Switzerland)2025

Synthesis and Antibacterial Evaluation of Chlorhexidine- and Triclosan-Impregnated Kaolinite Nanocomposites.

Aruzhan Alimbek, Zhanar Bekissanova, Bayansulu Otegenova, Ardak Jumagaziyeva, Bagashar B Zhaksybay, Yana Zhumadilova, Alyiya Ospanova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aruzhan AlimbekFaculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Zhanar BekissanovaFaculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Bayansulu OtegenovaFaculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.
Ardak JumagaziyevaScientific Center for Anti-Infectious Drugs, Almaty 050060, Kazakhstan.
Bagashar B ZhaksybayFaculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.ORCID 0009-0007-1654-5784
Yana ZhumadilovaDepartment of Chemistry, Nazarbayev University, Astana 010000, Kazakhstan.
Alyiya OspanovaFaculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan.

Funding

This research has been funded by the Science Committee of the Ministry of Education and Science of the Republic of Kazakhstan Grant No. AP19678726
6 · The paper itself

Abstract

Clay minerals are actively used to obtain a bioactive composite. Kaolinite, as a representative of clay minerals, possesses unique properties essential for the creation of biocomposite materials. This mineral, characterized by its distinctive layered structure, is chemically inert, highly stable, thermally resistant, eco-friendly, biocompatible, and non-toxic. Kaolinite, which plays the role of a carrier in this work, has such properties and can be the basis for biologically active composites. Antibacterial composites, namely, kaolinite/chlorhexidine and kaolinite/triclosan, were synthesized by impregnation of calcined and non-calcined samples of natural kaolinite with the antibacterial agents chlorhexidine and triclosan. The structure, morphology, elemental composition, and mineralogical characteristics of the natural and synthesized kaolinite/chlorhexidine (KAO/CHX) and kaolinite/triclosan (KAO/TCS) composites were investigated by methods of analysis such as X-ray diffraction, FTIR (Fourier-transform infrared) spectroscopy, and scanning electron microscopy. The calcined kaolinite/chlorhexidine composite at 500 °C (KAO

Indexed as

compositekaolinitekaolinite/chlorhexidinekaolinite/triclosan antibacterial activity

Identifiers

PMID39795819
PMCPMC11722152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.